Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical need.
Fishbain
David
D
Miller School of Medicine at the University of Miami, Mental Health Hospital Center, 1695 N.W. 9th Ave., Miami, FL 33136, USA. DFishbain@med.miami.edu
Johnson
Sandra
S
Webster
Lynn
L
Greene
Laurence
L
Faysal
Joanne
J
D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D002908:Chronic Disease; D011307:Drug Prescriptions; D004335:Drug and Narcotic Control; D006297:Health Services Accessibility / Q000331:legislation & jurisprudence*; D006301:Health Services Needs and Demand / Q000331:legislation & jurisprudence*; D006801:Humans; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D010146:Pain / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D010147:Pain Measurement; D018579:Patient Selection; D015397:Program Evaluation; D018570:Risk Assessment; D012307:Risk Factors
D000701:Analgesics, Opioid